The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
On-Demand Educational Webinars
Today, health systems are being forced to leverage disparate data from internal and external sources to drive business intelligence solutions. In…
Resources
The AHRMM Keys for Supply Chain Excellence are Key Performance Indicators (KPIs) that set the standard for supply chain management in the health care…
Advisory
EtO Quality Advisory
Overview:
The AHA and AHRMM have released a Quality Advisory on ethylene oxide sterilization of medical de
On-Demand Educational Webinars
The role of the supply chain is more important in health care than ever before due to the rising economic challenges that are faced today. This three…
Podcasts
Research has shown that at least 2/3 of leaders in healthcare supply chain are having real issues locating candidates with the necessary competenci
Podcasts
As we redefine healthcare into a value-based service, it is critical to develop the type of partner relationship where trust and respect are at the